PharmaForceIQ's Strategic Acquisition of Aktana: A New Era for Pharmaceutical Engagement
PharmaForceIQ's Strategic Acquisition of Aktana: A New Era for Pharmaceutical Engagement
In a significant strategic move, PharmaForceIQ has officially acquired Aktana, aiming to revolutionize customer engagement in the pharmaceutical sector. This acquisition is set to integrate PharmaForceIQ's advanced digital orchestration capabilities with Aktana's industry-leading AI-driven Next-Best-Action (NBA) platform.
A Game-Changer for Pharma Companies
The outcome of this merger is breathtaking—creating the first-ever optichannel-in-a-box solution for pharmaceutical companies. This integrated system promises to unify brand and field strategies and enhance executional alignment in just 6 to 8 weeks. This holistic solution measures impact immediately, thereby transforming how pharma companies engage their customers.
PharmaForceIQ's automation and seamless system aims to increase both efficiency and productivity, integrating its modular, machine learning-powered platform with Aktana's sophisticated AI core. This powerful combination promises long-term scalability and innovation across the expansive market.
Expanding Global Reach
The strategic acquisition allows PharmaForceIQ to deepen its presence in the U.S. pharmaceutical market while also virtue marketing capabilities in LATAM, APAC, and EMEA regions. This expansion significantly enhances their capacity for field engagement, providing deeper predictive insights that empower field teams to heighten their performance.
The NBA platform utilizes Aktana's proprietary Knowledge Nexus dataset, which draws on real-world insights from over 85 validated use cases, 100 million field suggestions, and over 5,000 executed tactics gathered over a span of twelve years. These stats reflect an undeniable impact within the field, accounting for:
- - A 36% increase in NBRx lift across clients.
- - A 19% increase in sales performance following competitor launches.
- - A saving of 20 minutes daily for each rep by minimizing manual tasks.
Quotes from Leadership
Hemal Somaiya, Chief Executive and Strategy Officer at PharmaForceIQ, expressed excitement about the acquisition, noting, “We’re thrilled to add these new capabilities to deepen our orchestration engine, making PharmaForceIQ the industry's only end-to-end go-to-market customer engagement platform.” He envisions utilizing these enhancements to scale operations across various global pharmaceutical entities, further implying that this synergy will enhance marketing performance under their existing capabilities.
Derek Choy, Head of Product at PharmaForceIQ and former Co-Founder of Aktana, further commented, “I am excited to bring our pioneering Field Orchestration platform to PharmaForceIQ. This move will elevate our product, enabling best-in-class orchestration across both field and digital.” This remark highlights the new unified platform's intent to provide an integrated customer understanding for drug sales teams.
Transforming Engagement Strategies
The move to apply optichannel engagement across both field and digital domains stands to significantly enhance operational efficiency throughout the commercial functions of pharmaceutical companies. PharmaForceIQ anticipates a potential:
- - 3x average increase in script lifts.
- - A compelling 22% increase in brand strategy adherence.
- - An astounding 80% rise in HCP engagement rates.
- - Potential savings of 20-30% over traditional marketing strategies compared to existing models.
Enhancements to Happening Fast
Over the past two years, Aktana has made substantial enhancements to its platform, focusing on progress like AI-powered communications planning, automated tactic optimization, and offering live strategic visibility to improve the health care professional journey. Now, with the backing of PharmaForceIQ's support, these developments can be expected to progress further, backed by a dedicated team that proudly boasts a 100% client renewal rate.
In closing, Canaccord Genuity served as the sole financial advisor throughout this transformative transaction. For more insights into how PharmaForceIQ's AI-powered platform can provide a competitive edge across various engagement channels, exploring their offerings at pharmaforceiq.com is highly encouraged.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.